Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Assets (2023 - 2025)

Historic Current Assets for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $66.6 million.

  • Rallybio's Current Assets fell 1483.19% to $66.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.6 million, marking a year-over-year decrease of 1483.19%. This contributed to the annual value of $67.8 million for FY2024, which is 4089.94% down from last year.
  • Per Rallybio's latest filing, its Current Assets stood at $66.6 million for Q3 2025, which was down 1483.19% from $50.3 million recorded in Q2 2025.
  • Rallybio's 5-year Current Assets high stood at $161.3 million for Q1 2023, and its period low was $50.3 million during Q2 2025.
  • Over the past 3 years, Rallybio's median Current Assets value was $91.4 million (recorded in 2024), while the average stood at $96.9 million.
  • Over the last 5 years, Rallybio's Current Assets had its largest YoY gain of 1483.19% in 2025, and its largest YoY loss of 4502.71% in 2025.
  • Over the past 3 years, Rallybio's Current Assets (Quarter) stood at $114.8 million in 2023, then plummeted by 40.9% to $67.8 million in 2024, then fell by 1.79% to $66.6 million in 2025.
  • Its last three reported values are $66.6 million in Q3 2025, $50.3 million for Q2 2025, and $57.4 million during Q1 2025.